real-time news and commentary for investors
Monday, Dec 17
2012, 3:47 PM
Cell Therapeutics (CTIC +2.8%) moves higher today after publishing positive results from a...
Cell Therapeutics (CTIC +2.8%) moves higher today after publishing positive results from a pre-clinical study of Pixuvri in The Journal of Pharmacology and Experimental Therapeutics. The study showed that in a human cardiac tissue model treated with Pixuvri did not form reactive oxygen species or long lived hydroxymetabolites. Additionally, the drug inhibited formation of the long-lived hydroxymetabolite of doxorubicin, which suggests a low incidence of cardiotoxicity.